comparemela.com

Latest Breaking News On - Acquipharma holdings - Page 1 : comparemela.com

Bugworks Research Inc secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa India), led by Lightrock India

Bugworks Research, a clinical stage multi-indication therapeutics company, today announced the financing of US$18M Series B1.

Kiran mazumdar shawJim oneillAnand anandkumarTejasvi raviAcquipharma holdingsGlobal brain corporationGermany federal ministry of educationFeatherlite group indiaBugworks researchUniversity of tokyo edge capitalBugworks research incKim holdingsAgreement numberLightrock indiaTokyo edge capitalFeatherlite group

Bugworks Research Inc secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock I

This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) BANGALORE, India,.

South australiaKiran mazumdar shawBala subramanianPooja balachandranJim oneillShahul hameedArchana jainAnand anandkumarTejasvi raviSantanu dattaAcquipharma holdingsGlobal brain corporationGermany federal ministry of educationFeatherlite group indiaBugworks researchUniversity of tokyo edge capital

Kiran Mazumdar-Shaw-backed Bugworks Research raises $18 mm

The funds will help the company support its anti-bacterial agent and develop therapeutics for serious underserved conditions

Kiran mazumdar shawJim oneillAnand anandkumarTejasvi raviAcquipharma holdingsGlobal brain corporationFeatherlite group indiaBugworks researchUniversity of tokyo edge capitalBugworks research incKim holdingsLightrock indiaLord jimo neillAntimicrobial resistanceExecutive chairpersonBiocon limited

Biotech Startup Bugworks Raises $18 Mn From Lightrock, Others

Bengaluru-based biotech startup Bugworks Research has announced a $18 Mn Series B1 round led by Lightrock India

United statesKiran mazumdar shawMoez dayaAnand anandkumarZumutor biologicsAcquipharma holdingsGlobal brain corporationFeatherlite group indiaLetsventure angel fundCentre for cellularBugworks researchUniversity of tokyo edge capitalKim holdingsLightrock indiaTokyo edge capitalSouth africa based acquipharma holdings

Bugworks Research Inc secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa India), led by Lightrock India

Bugworks Research, a clinical stage multi-indication therapeutics company, today announced the financing of US$18M Series B1.

Kiran mazumdar shawJim oneillAnand anandkumarTejasvi raviAcquipharma holdingsGlobal brain corporationGermany federal ministry of educationFeatherlite group indiaBugworks researchUniversity of tokyo edge capitalBugworks research incKim holdingsAgreement numberLightrock indiaTokyo edge capitalFeatherlite group

vimarsana © 2020. All Rights Reserved.